October 3rd Biotech Update

I am really torn on the market right now.  There is not a lot going on in biotech to make it really capable of swimming against the current (if the broader market weakens) and so I think macro really matters.  I want to focus on two macro issues that I think are weighing on the […]

September 29th Biotech Update

As much as we had a good day early this week, the market looks really tenuous.   I have seen some statistics about position that look quite bullish (i.e. investors are extremely under-invested) but I have also seen some statistics that show the interest rates have move very fast and the market needs to catch up […]

September 27th Biotech Update

The broader market continues to have issues with rates and inflation, although the sector did a little better yesterday.  I fully expect the sector to outperform today and would be quite disappointed if not for a longer period of time.  We finally have something to be a little excited about and it came from a […]

September 26th Biotech Update

A green start to the week?  It seems that way but after last week, it seems a little less than exciting.  Is this simply the rally that resets the oversold conditions for another leg lower or is this the rally that stops the bleeding and starts to build a new base?  Who really knows but […]

September 23rd Biotech Update

It has not been a good week for the market or the sector. We have clearly broken down and interest rate concerns are probably going to at best keep a lid on the upside and at worst continue the downside.  I do not think it was a coincidence that the sector seemed to get it […]

September 21st Biotech Update

The sector has managed to not breakdown and that is good.  We are still in a precarious position with the macro still having the potential to drive us down regardless of the fundamentals.  It really depends on the rate increase and how much the sector has priced in that action.  We know that rates are […]

September 19th Biotech Update

A slow start to the week but unfortunately not a good start to the sector.  We are at a critical area as I think the $80 level needs to hold on the XBI to limit the potential for a clear breakdown.  This has been support and resistance and a break below would not be a […]

September 14th Biotech Update

Well, that was not a great day.  Interest rates and risk off are not kind to the sector.  As long as we can hold support I think we will be fine.  I am not convinced that this is going to be a large and sustained sell off as opposed to a quick adjustment.  I get […]

September 13th Biotech Update

Today is going to be a macro day.  The CPI data was a little too hot for the market.  While I think we have likely seen peak inflation, it probably takes time for it to really cool down and likely involves more rate hikes and a slowing down of the economy (if not recession).  The […]

September 9th Biotech Update

The market did well yesterday and hopefully we can build on that into the weekend.  The ideal scenario is that old level that we broke out of ends up being the support that we use to move higher.  Yesterday was a good start for that process but we need continuation. GILD announced some more detailed […]

August 15th Biotech Update

A slow start to the week but that is not necessarily bad.  The sector has been strong and there has been nothing to change it.  I think the biggest news has been outside the sector with the decline in the Empire State index, but I imagine that might not been a massive surprise (perhaps the […]

August 10th Biotech Update

Did we have that pullback that refreshed?  Sort of.  We went down to what was resistance and have bounced but it was a quick little move.  In some ways, a move down to the $87 level on the XBI would be the former resistance and I will be really looking to see if we make […]

August 8th Biotech Update

A good start to the week and it should continue the momentum for the sector.  While I think we still can move on the news, it is also the case that the sector has had a nice run recently.  Nothing goes up (or down forever) and the longer the run, the better the news has […]

August 4th Biotech Update

Are we finally starting to see the wheels of M&A loosen?  Perhaps.  We got some this morning as well as a new rumor.  It is enough to move the sector (at least a little).  We are definitely in a different spot as the news is actually moving the sector higher.  It was not that long […]

August 3rd Biotech Update

We started the week at the bottom of the range and within three days we are at the top of the range.  I find days like this a little tough to judge.  Big positive moves like this make it feel like there is very strong momentum but when they smack against the top of a […]

The XBI – A Short Term Outlook

Many are asking if the XBI is done with the bounce and will drop back to test the 52-week low around $61, or it is still in a consolidation mode and will continue the recovery and move upward again! Here is my outlook for the biotech sector these days. The XBI used as a leading […]

August 1st Biotech Update

  We have some more earnings this week but the lack of exciting launches to track make them a little less exciting.  Of course, there could be some unexpected misses (see below) but I generally expect earnings to be more or less in than with expectations.  The sector has been essentially rangebound the entire month […]

July 29th Biotech Update

I have had family in town that has changed my schedule and so it has been slow on the updates this week.  There is growing optimism in the sector and I suspect that we could outperform the rest of the year.  Maybe I am crazy but as long as the fundamentals do not crash in […]

July 21st Biotech Update

A slow week but a good week for the sector.  We are entering earnings and that might provide a little boost or drag but it has been awhile since an earnings season really seemed to impact the sector.  They can affect individual stocks but the quarters where you have broad read throughs seem to have […]

July 14th Biotech Update

The sector seems to be doing ok as we inch closer to earnings season.  It will be interesting to see how the sector moves on earnings as there is nothing that should really surprise anyone.  There are still some issues outside the companies that could impact trading.  There is some drug pricing reforms being discussed […]